HomeSRT3 • FRA
Sartorius AG Preference Shares
€257.10
Sep 27, 10:59:31 PM GMT+2 · EUR · FRA · Disclaimer
StockDE listed security
Previous close
€248.10
Day range
€247.30 - €257.30
Year range
€203.80 - €382.60
Market cap
16.97B EUR
Avg Volume
73.00
P/E ratio
226.27
Dividend yield
0.28%
CDP Climate Change Score
C
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
860.70M3.45%
Operating expense
282.00M8.75%
Net income
23.90M-74.84%
Net profit margin
2.78-75.66%
Earnings per share
1.14-9.52%
EBITDA
206.10M1.38%
Effective tax rate
26.53%
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
591.20M264.49%
Total assets
9.94B41.18%
Total liabilities
6.13B41.43%
Total equity
3.81B
Shares outstanding
69.04M
Price to book
6.33
Return on assets
2.58%
Return on capital
3.06%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
23.90M-74.84%
Cash from operations
301.40M88.14%
Cash from investing
-103.60M45.27%
Cash from financing
-709.10M-2,455.81%
Net change in cash
-511.60M-5,267.68%
Free cash flow
60.61M134.06%
About
Sartorius AG is an international pharmaceutical and laboratory equipment supplier, covering the segments of Bioprocess Solutions and Lab Products & Services. In September 2021, Sartorius has been admitted to the DAX, Germany's largest stock market index. As a leading partner to the biopharmaceutical research and industry, Sartorius supports its customers in the development and production of biotech drugs and vaccines - from the initial idea in the laboratory to commercial production. Sartorius conducts its operating business in the two divisions Bioprocess Solutions and Lab Products&Services. The divisions bundle their respective businesses according to the same application areas and customer groups. The divisions share some of the infrastructure and central services. Wikipedia
Founded
1870
Employees
14,143
Search
Clear search
Close search
Google apps
Main menu